Evidence map›Paper›PMID 28975381›Full record

ArticleEuropean journal of clinical pharmacology2018

Health status and drug use 1 year before and 1 year after skilled nursing home admission during the first quarter of 2013 in France: a study based on the French National Health Insurance Information System.

Alice Atramont, Dominique Bonnet-Zamponi, Isabelle Bourdel-Marchasson, Isabelle Tangre, Anne Fagot-Campagna, Philippe Tuppin

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Alice AtramontCaisse Nationale d'Assurance Maladie (CNAMTS), Paris, France.
Dominique Bonnet-ZamponiCentre de pharmaco-épidémiologie de l'APHP, OMEDIT Observatoire des MEdicaments Dispositifs médicaux et Innovations Thérapeutiques d'Ile de France, Paris, France.
Isabelle Bourdel-MarchassonClinical gerontology department, Centre Henri Choussat, Xavier Arnozan Hospital, Pessac, France.
Isabelle TangreKorian Bonisiaca Nursing Home, Bondy, France.
Anne Fagot-CampagnaCaisse Nationale d'Assurance Maladie (CNAMTS), Paris, France.
Philippe TuppinCaisse Nationale d'Assurance Maladie (CNAMTS), Paris, France. philippe.tuppin@cnamts.fr.
l'Assurance Maladie · FRAssistance Publique – Hôpitaux de Paris · FRConservatoire National des Arts et Métiers · FRHôpital Xavier Arnozan · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeChanges in prescribing practices following skilled nursing home (SNH) admission have not been clearly described in France. The study aimed to evaluate health status and drug use 1 year before and 1 year after admission to SNH.

methodPeople ≥ 65 years old admitted to SNH in the first quarter of 2013, covered by the national health insurance general scheme (69% of the population of this age) and still alive 1 year after admission were identified in a specific database (Resid-ehpad). Linking with the National Health Insurance Information System (SNIIRAM) allowed analysis of their health status, identified by algorithms, and changes in their use of reimbursed drugs.

resultsIn a population of 11,687 residents (mean age: 86 years, women: 76%), the most prevalent diseases were cardiovascular/neurovascular diseases (45%) and dementias (35%). The use of certain chronic treatments (≥ 3 reimbursements/year) increased significantly (p < 0.001) after nursing home admission: antidepressants: 34 to 46%, anxiolytics: 32 to 42%, hypnotics/sedatives: 18 to 24%, antipsychotics: 10 to 21% (14 to 30% in patients with dementia). The use of lipid-modifying agents and agents acting on the renin-angiotensin system decreased significantly (33 to 24% and 44 to 37%, respectively, p < 0.001). The use of antibacterials (≥ 1 reimbursement/year) increased also significantly (p < 0.001): 45 to 61%, including quinolones (13 to 20%) and third-generation cephalosporins (10 to 18%).

conclusionThese results reveal increased prescribing of psychotropic drugs and antibacterials in SNH, requiring the development or sustainability of actions designed to improve prescribing practices in older people targeted by these treatments.

Indexed as

Health StatusSkilled Nursing FacilitiesAged, 80 and overAnti-Bacterial AgentsDatabases, FactualDrug PrescriptionsDrug UtilizationFemaleFranceHumansMaleNational Health ProgramsPsychotropic DrugsAnti-Bacterial AgentsPsychotropic DrugsDrug therapyElderlyNursing homeObservational study

Identifiers

PMID28975381
OpenAlexW2762696253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.